Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardian Pharmacy Services (GRDN) Receivables (2023 - 2025)

Guardian Pharmacy Services (GRDN) has disclosed Receivables for 3 consecutive years, with $101.6 million as the latest value for Q4 2025.

  • Quarterly Receivables rose 4.59% to $101.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $101.6 million through Dec 2025, up 4.59% year-over-year, with the annual reading at $101.6 million for FY2025, 4.59% up from the prior year.
  • Receivables hit $101.6 million in Q4 2025 for Guardian Pharmacy Services, down from $106.2 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $106.2 million in Q3 2025 to a low of $77.3 million in Q4 2023.
  • Historically, Receivables has averaged $95.0 million across 3 years, with a median of $97.2 million in 2024.
  • Biggest five-year swings in Receivables: increased 25.74% in 2024 and later grew 4.59% in 2025.
  • Year by year, Receivables stood at $77.3 million in 2023, then rose by 25.74% to $97.2 million in 2024, then grew by 4.59% to $101.6 million in 2025.
  • Business Quant data shows Receivables for GRDN at $101.6 million in Q4 2025, $106.2 million in Q3 2025, and $94.1 million in Q2 2025.